Rtw Investments »

Celcuity shares owned by Rtw Investments

Quarter-by-quarter ownership of Celcuity (CELC) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Celcuity

Tip: Access up to 7 years of quarterly data

All positions including Celcuity held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celcuity by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $55M 550k 99.74

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Cogent Biosciences (COGT)
Penumbra (PEN)
Irhythm Technologies (IRTC)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
ACADIA Pharmaceuticals (ACAD)
Establishment Labs Holdings Ord (ESTA)

View all positions for Rtw Investments

Top funds holding Celcuity

Baker Bros. Advisors
NEA Management Company
venBio Select Advisor
Perceptive Advisors
BlackRock
Vanguard Group
Soleus Capital Management
Deerfield Management Company
State Street Corporation
Tang Capital Management
Geode Capital Management
Sio Capital Management
Holocene Advisors
BVF
Goldman Sachs Group

View all funds holding Celcuity